Financial News
Latest News about MRK
Recent news which mentions MRK
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
From Benzinga
Will Investors Benefit From Johnson & Johnson's Breakup?
November 23, 2021
From Motley Fool
Orally Administered Covid-19 Treatment Should Bolster Merck’s Value
November 22, 2021
Tickers
MRK
From InvestorPlace
3 Falling-Star Stocks to Buy Into the Holidays
November 22, 2021
From InvestorPlace
Covid Stand-out Pfizer’s Albert Bourla Gets My Vote for CEO of the Year
November 22, 2021
From InvestorPlace
From Motley Fool
Is Merck Stock a Buy?
November 20, 2021
From Motley Fool
EU Backs Merck's COVID-19 Pill For Adults At Risk Of Severe Illness
November 19, 2021
Tickers
MRK
From Benzinga
Pills to treat COVID-19 will be game-changers, but the best strategy remains prevention
November 19, 2021
From MarketWatch
3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio
November 19, 2021
From InvestorPlace
Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
November 19, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
Skipping Eye Exams Linked to Nearly 6 Million Cases of Preventable Vision Loss, According to Vision Care Experts
November 19, 2021
From Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
From Benzinga
Merck's Keytruda Scores First Approval In Adjuvant Kidney Cancer Setting
November 18, 2021
Tickers
MRK
From Benzinga
Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3
November 18, 2021
From Benzinga
From Motley Fool
From Benzinga
Why Atea Pharmaceuticals Stock Is Sinking Today
November 17, 2021
From Motley Fool
Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows
November 17, 2021
From Motley Fool
Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters
November 16, 2021
From Benzinga
Here’s why tech could be the sweet spot for next year, but this hot sector is a no, says Wells Fargo
November 16, 2021
From MarketWatch
Merck Is a Dividend Play Ready to Get Back in Gear
November 16, 2021
From InvestorPlace
From Benzinga
Celltrion shares rally in South Korea after EU OKs marketing of its COVID-19 treatment
November 14, 2021
Tickers
MRK
From MarketWatch
Better Buy: Bristol Myers Squibb vs. Merck
November 13, 2021
From Motley Fool
Pfizer: Bull vs. Bear
November 13, 2021
From Motley Fool
Is Merck's Planned Acquisition of Acceleron in Trouble?
November 12, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
